Epigenetic reader domain inhibitor Molibresib besylate, Purity ≥98%

Cat. No.: X24-05-ZQ463

Epigenetic reader domain inhibitor Molibresib besylate, Purity ≥98%

Synonym: 1895049-20-3; GSK 525762C; GSK-525762C; GSK525762C; I-BET 762 besylate; I-BET762; I-BET-762; Epigenetic reader domain inhibitor

  • CAS Number: 1895049-20-3
  • Compound CID: 133082230
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Molibresib besylate disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
582.07
Molecular Formula
C28H28ClN5O5S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Molibresib besylate is used to investigate the therapeutic potential of BET inhibition in oncology.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.